NCT07006285View on ClinicalTrials.gov

T2 Biomarkers Predictive Value in Occupational Asthma After Cessation of Exposure.

NANot yet recruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
AsthmaOccupational AsthmaOccupational Diseases
Interventions
OTHER

Measure of T2 biomarkers

"T2 Biomarkers are estimated via induced sputum:~Sputum is induced through increasing concentrations from 0.9 or 3% to 4% and 5% of hypertonic solution.~Assessment of nonspecific bronchial hyperresponsiveness is realized by metacholine challenge"

Trial Locations (1)

67000

University Hospital of Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT07006285 - T2 Biomarkers Predictive Value in Occupational Asthma After Cessation of Exposure. | Biotech Hunter | Biotech Hunter